Medicine
TOBI Podhaler 28 mg inhalation capsule
TOBI Podhaler 28 mg inhalation capsule is a prescription medicine containing Tobramycin for inhalation, oral use, marketed by Viatris Specialty, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). The…
Key facts
- Active ingredient (INN)
- Tobramycin
- Brand
- TOBI Podhaler
- Strength
- 28 mg
- Dosage form
- Inhalation capsule
- Route
- Inhalation, oral
- Packs
- 4 package
- Marketing authorisation holder
- Viatris Specialty
- Manufacturer
- Viatris Specialty
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). The Podhaler device should not be used with any other capsules. • Capsules should always be stored in the blister and each capsule should only be removed immediately before use. • Always use the new Podhaler device provided with each weekly pack.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01GB01 Tobramycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2021
- Identifiers
- RxCUI 1374569, 1374570, 1374573 +5DailyMed set ID c4b5bb1f-e158-4ac1-9c35-e98a416c743aNDC 49502-401Application NDA201688
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 package in 1 box, unit-dose / 7 blister pack in 1 package / 8 capsule in 1 blister pack | 49502-401-24 | Viatris Specialty | 1 September 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tobramycin
Clinical summary
Tobramycin is an aminoglycoside antibacterial indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. It is available as inhalation solution, eye drops and injection for ophthalmic and intravenous use. MedsAcross supplies Tobramycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TobramycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TOBREX prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Tobi Podhaler: European public assessment report (EPAR) · European Medicines Agency
- Vantobra (previously Tobramycin PARI): European public assessment report (EPAR) · European Medicines Agency
Need TOBI Podhaler 28 mg inhalation capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.